Sunday, May 01, 2022


Study Links Increase in Emergency Heart Events With COVID-19 Vaccine Rollout

A new study found a correlation between an increase in emergency cardiovascular events among people under 40 years of age during the launch of Israel’s COVID-19 vaccine program.

Published in the Nature journal, researchers utilized data from the Israel National Emergency Medical Services between 2019 and 2021 that evaluated emergency, or EMS, calls among 16- to 39-year-olds across Israel “with potential factors including COVID-19 infection and vaccination rates.”

They found that there was a 25 percent increase in EMS calls between January 2021 to May 2021, as compared with the years 2019 and 2020. Israel, which primarily uses Pfizer’s mRNA vaccine, launched its COVID-19 vaccine program in late December 2020.

“The weekly emergency call counts were significantly associated with the rates of 1st and 2nd vaccine doses administered to this age group but were not with COVID-19 infection rates,” they found. “While not establishing causal relationships, the findings raise concerns regarding vaccine-induced undetected severe cardiovascular side-effects and underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals.”

They recommend that when evaluating possible vaccine side-effects and COVID-19 outcomes, officials should incorporate EMS data and relevant data to identify potential new health trends such as an increase in EMS calls, and “promptly investigate potential underlying causes.”

A recent study carried out by Swedish researchers across populations in Finland, Denmark, Sweden, and Norway suggested that heart inflammation requiring hospital care was more common among people who received COVID-19 vaccines than individuals who did not.

“These extra cases among men aged 16 to 24 correspond to a 5 times increased risk after Comirnaty and 15 times increased risk after Spikevax compared to unvaccinated,” Dr. Rickard Ljung, a professor and physician at the Swedish Medical Products Agency who was involved in the study, told The Epoch Times last week. Spikevax is the name for Moderna’s COVID-19 vaccine, while Comirnaty is Pfizer’s vaccine.

His team found that myocarditis or pericarditis rates are higher than the levels in an unvaccinated cohort, or 38 per 100,000 after second doses of the mRNA vaccines were administered.

The Israeli research team said in their study, published on April 28, that they believe the “benefits of COVID-19 vaccination are clear, especially for populations at great risk of developing serious and potentially life-threatening illness” such as older adults or immunocompromised individuals. However, they noted, “it is important to better understand the potential risks to minimize potential harm.”

When conducting the research, the Israeli scientists made note of several potential flaws, including a “self-reporting bias” when individuals report symptoms via report systems including the U.S. federal government-run Vaccine Adverse Event Reporting System (VAERS), including “under and over-reporting” of vaccine-related symptoms.

“Even the study from Israel that is based on more proactive data collection mentions that some of the potentially relevant cases were not fully investigated,” they said.

A second issue the researchers ran into is how the symptoms of myocarditis, a type of heart inflammation, present themselves.

“Myocarditis is a particularly insidious disease with multiple reported manifestations,” they noted. “There is vast literature that highlights asymptomatic cases of myocarditis, which are often underdiagnosed.”

Meanwhile, “myocardial injury and myocarditis [are] prevalent among patients with COVID-19 infection,” not just among those who received the vaccine, it said.

“As COVID-19 vaccine rollouts often take place with background community COVID-19 infections, it could be challenging to identify whether increased incidence of myocarditis and related cardiovascular conditions … is driven by COVID-19 infections or induced by COVID-19 vaccines,” it added.

The U.S. Centers for Disease Control and Prevention and most health agencies worldwide have said that the benefits of COVID-19 vaccines outweigh the potential risks. The CDC on its website says that most patients who develop myocarditis or pericarditis and got medical care have responded well to treatment.

Symptoms include chest pain, shortness of breath, and feelings of a fast-beating or fluttering heart

**************************************************

Increase in Reactivated Viruses Following COVID-19 Booster Shots: Dr. Richard Urso

Some viruses, after initial infection, remain latent in the body for a lifetime and may reactivate to cause infection again or a different condition. These kinds of latent viruses are being reactivated in a large number of people following their booster COVID-19 shots, causing symptoms of long COVID and other health conditions, according to Dr. Richard Urso.

Long COVID is a condition where people experience ongoing, recurring, or new health problems weeks to months after first being infected with SARS-CoV-2, the virus that causes COVID-19, or receiving a COVID-19 injection. Symptoms may include brain fog, fatigue, chest pain, and insomnia, among others.

“So in my clinic right now, I am seeing three to five people a week because they know that I am taking a lot of time in my practice to do COVID, and they’re coming to see me with long COVID and … with problems after the vaccine,” Urso, an ophthalmologist, a drug design and treatment specialist, and co-founder of the International Alliance of Physicians and Medical Scientists, told EpochTV’s “American Thought Leaders” program. “And what I’m finding is a huge number of them have reactivated Epstein-Barr, herpes simplex, herpes zoster, CMV.”

Of the more than 100 species of herpesviruses, eight are known to infect humans and remain in the body for life after the primary infection has cleared, and which can reactivate later under certain conditions:

Most people are unaware that they’ve been infected with some of these viruses as they experience no symptoms.

“A lot of people are looking at this long COVID as if it’s all viral related problems, specifically to the spike protein or to other issues. They don’t know that we’re seeing this huge reactivation in the herpesvirus family and we have treatment for it. It’s been working really really well,” Urso said.

While there is still no standard clinical definition or treatment for Long COVID, Urso says that there are many different repurposed drugs doctors can prescribe off-label to treat the syndrome, such as those used in the I-RECOVER protocol, developed by The Front Line COVID-19 Critical Care Alliance.

For long COVID symptoms caused by one of the reactivated herpesviruses, Urso says he prescribes Valtrex and supplements like lysine and vitamin D.

“We use lysine because it’s one of those nutritionals that’s good against the herpesvirus family. The ratio of lysine-arginine seems to impact the ability of these viruses to replicate,” Urso said.

He added, “I tell people vitamin D is your data analyst. It allows the immune system to make good decisions … And when vitamin D is around, your immune system can recognize, ‘Oh, this is pollen, let’s leave it alone. Let’s attack this pathogen, let’s attack this cancer.’”

Urso said he’s been recommending vitamin D since 1995 when he was the chief of orbital oncology at MD Anderson Cancer Center. He came upon a study that showed the supplement “had some impact on a tumor recognition protein” and began to test all of his patients’ vitamin D levels.

“Virtually 100 percent of the patients were vitamin D deficient with cancer, colon cancer particularly, we became aware of it,” Urso said, adding that vitamin D has also been “amazing for allergies, it’s amazing for prevention, and resistance against cancer, particularly lymphomas and breast cancer.”

Treating COVID Patients

When the pandemic began, Urso said that he couldn’t stay quiet knowing that COVID-19 can be treated early with various repurposed drugs and “reluctantly started treating” patients as a result of other doctors refusing to prescribe early treatment.

“I told my patients if you have COVID, nobody is going to help you. I said, first go through the chain, [and] if no one’s going to help you, I’ll help you,” Urso said.

More than two years into the pandemic, the Centers for Disease Control and Prevention (CDC) continues to tell people to stay home unless they show “emergency warning signs” that include difficulty breathing, new confusion, and persistent chest pain or pressure.

The health agency only began recommending in January 2022 that individuals at high risk of developing severe disease should seek early treatment with one of the emergency authorized medications when they test positive for COVID-19.

Throughout the pandemic, the CDC has not recommended people to take vitamin D. Studies have shown that vitamin D can help prevent COVID-19, reduce admission to the intensive care unit, and significantly reduce mortality. A study from Israel found that people who were vitamin D deficient were 14 times more likely to have severe COVID-19.

Lipid Nanoparticles

Lipid nanoparticles (LPNs) are tiny particles made up of lipids or fat that act as a delivery system by encapsulating the mRNA that encodes the SARS-CoV-2 spike protein into the human cells.

Without the LPNs, the mRNA would degrade in a matter of seconds once injected into the arm.

Studies have found that the LPNs are not degrading and being eliminated from the body in the 36-hour time frame the FDA recently told The Epoch Times about, nor do they stay only at the injection site.

The Japanese regulatory agency’s biodistribution study (pdf) of the Pfizer vaccine showed that some of the mRNA moved from the injection site and through the bloodstream, and was found in various organs such as the liver, spleen, adrenal glands, and ovaries of rats 48 hours following injection.

“This is something that I would have known quite readily because I work with lipid nanoparticles,” Urso said. “I could have told you that lipid nanoparticles, I usually say, they need a door crack [to leave the injection site], whereas a virus needs an open door.”

Since a normal vaccine requires an “open door” to distribute to other parts of the body, Urso says, “a normal vaccine stays in the arm, pretty much 99.9 percent or 99 percent,” while “a large majority” of LPNs will not stay in the arm.

“In fact, we now know that a large part of it goes into the lymph node right underneath here, and is still making spike protein 60 days later,” Urso said, adding that the spike protein “is actually being found up to 15 months later, in monocytes and other cells, it’s not being degraded.”

Urso says that the persistence of spike protein in different parts of the body is interfering with the immune system’s normal functions and causing health problems.

“It’s blocking important tumor repairing genes called p53, it’s blocking BRCA [genes], it’s also messing with microRNA-27A, which is causing upticks in colon cancer cells,” Urso said.

Urso says that the presence of spikes and LPNs is also “messing with Toll-like receptors 7 and 8,” which are “important for immune surveillance for viruses.”

“So we’re going to see this huge uptick in all the viruses that lay kind of dormant in our body like herpesvirus family.”

********************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

https://westpsychol.blogspot.com/ (The Psychologist -- backup)

**************************************************

No comments: